Aims and Scope

The goal of the journal is to provide pediatric ophthalmologists with data on pediatric ophthalmology issues, to enable exchange of experience in diagnosing and treating ocular diseases in children, to facilitate discussion of research results, and to improve pediatric eye care.

 

Sections

Clinical studies

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Experimental studies

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Ophthalmic care organization for children

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Reviews

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Discussion

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Clinical recomendations

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Inforation messages

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process

Peer-Review Policy

All articles submitted to the editorial office of a journal shall be reviewed in the manner set forth below.

1. The editorial staff shall establish whether the submission is within the scope of the journal and meets the format criteria. The editorial staff shall then forward it either to the Editor-in-Chief, to the Deputy Editor-in-Chief or to the Executive Editor, who shall decide whether the research results described in the article are valid and important. If the results are deemed valid and important, reviewers shall be determined. All articles shall be reviewed by the Editorial Board and the Editorial Council, as well as by independent reviewers. Independent reviewers must be leading experts in the field and have some publications (not older than three years) on the subject covered in the submitted article. Articles submitted by the Editor-in-Chief shall be reviewed by independent reviewers.

2. The review process is confidential. The editorial staff shall send the author/s copies of the reviews or a rejection letter. The editorial staff shall also send copies of the reviews to the Ministry of Education and Science of the Russian Federation, upon a request from the Ministry.

3. The review process requires 2 months. The editorial staff controls the length of the review process; in some circumstances (upon a reviewer’s request), more time may be given to complete the review.

4. To help produce a comprehensive and unbiased review of an article, Editorial Team has developed Instructions for Reviewers that contain a list of criteria to be assessed. Based on the assessment of the criteria, reviewers shall be asked to determine the status of the article in one of the following ways: (a) accept, (b) accept with revision as suggested by the reviewer, (c) re-review required, or (d) reject.

5. A review suggesting corrections and revisions to the submitted article shall be forwarded by the editorial staff to the author, who will be requested either to prepare a revised version of the article based on the recommendations made by the reviewer or to prove that such corrections and/or revisions are not needed. A revised article shall be sent to the reviewers to be re-reviewed.

6. In cases of irreconcilable differences between the author and reviewer, the Editorial Board reserves the right to send the article to another reviewer. Should a conflict arise, the article shall be sent to a member of the Editorial Board or Editorial Council. The final decision shall rest with the Editor-in-Chief.

7. Authors may be requested to list names of potential reviewers when submitting a publication.

8. Submitted articles may be sent to an expert in medical statistics for an additional review.

9. The author shall be notified of a negative review by email.

10. A positive review does not obligate the journal to publish the submitted article. The final decision shall be made by the Editorial Board based on whether the article presents valid data and is in scope for the journal.

11. Authors may appeal a rejection of their article by the editors. 

12. Originals of the reviews shall be stored at the editorial office for 5 years.

 

Publication Frequency

Frequency: 4 issues per year

 

Author Self-Archiving

This journal does not permit authors to post items submitted to the journal on personal websites or institutional repositories.

 

Issue Purchase

Readers without a subscription may still purchase individual issues. The following payment options and fees are available.

Access for an Issue: 35.00 (USD)

You can purchase the access for all articles published in one issue. Access to articles will be provide for an unlimited time.

Access to issue allows you to read, download and print full text (PDF and HTML) of all articles, but does not allow to distribute, copy or reproduce articles materials until the end of the embargo period (3 years) since the publication of the article).

 

Article Purchase

Readers without a subscription may still purchase individual articles. The following payment options and fees are available.

Access for an Article: 5.00 (USD)

You can purchase the access for the article to read, download and print its fulltext (PDF, HTML). Access to article will be provide for an unlimited time.

Purchased access does not allow to distribute, copy or reproduce article's materials until the end of the embargo period (3 years) since the publication of the article).

 

Editorial Board

Editor-in-chief:
Lyudmila A. KATARGINA – MD, PhD, Prof., Honored Doctor of the Russian Federation, Chief Visiting Pediatric Ophthalmologist of the Ministry of Health of the Russian Federation, Member of the Trans-Regional Association of Ophthalmologists, Head of the Department of Pediatric Ophthalmology, Deputy Director for Science, Moscow Helmholtz Research Institute of Eye Diseases (Moscow, Russia)

Assistant editor-in-chief:
Marina R. GUSEVA – MD, PhD, Prof., Department of Ophthalmology, Pediatric Faculty, Pirogov Russian National Research Medical University (Moscow, Russia)

Elena P. TARUTTA – MD, PhD, Prof., Head of the Department of Refractive Pathology, Binocular Vision and Ergonomics in Ophthalmology, Moscow Helmholtz Research Institute of Eye Diseases (Moscow, Russia)

Executive Secretary:
Nadezhda A. GVOZDYUK – MD, PhD, Junior Researcher, Department of Pediatric Ophthalmology, Moscow Helmholtz Research Institute of Eye Diseases (Moscow, Russia)

Scientific Editor:
Natalia N. ARESTOVA – MD, PhD, Leading Researcher, Department of Pediatric Ophthalmology, Moscow Helmholtz Research Institute of Eye Diseases (Moscow, Russia)

Alevtina F. BROVKINA – MD, PhD, Prof., Academician of the Russian Academy of Sciences, Head of the Course on Ophthalmic Oncology and Orbital Pathology, Department of Ophthalmology, Russian Medical Academy of Postgraduate Education (Moscow, Russia)

Tatiana B. KRUGLOVA – MD, PhD, Chief Researcher, Department of Pediatric Ophthalmology, Moscow Helmholtz Research Institute of Eye Diseases (Moscow, Russia)

Elena Yu. MARKOVA – MD, PhD, Prof., Department of Ophthalmology, Peoples’ Friendship University of Russia, Chief Visiting Pediatric Ophthalmologist of Moscow, Vice-president of the Association for Pediatric Ophthalmology of Russia and CIS Countries (Moscow, Russia)

Ilya M. MOSIN – MD, PhD, Prof., Department of Ophthalmology, Tushinskaya Children’s Hospital (Moscow, Russia)

Larisa K. MOSHETOVA – MD, PhD, Prof., Academician of the Russian Academy of Sciences, Rector, Head of the Department of Ophthalmology, Head of the Course on Pediatric Ophthalmology, Ocular Oncology and Orbital Pathology, Russian Medical Academy of Postgraduate Education, Chief Visiting Ophthalmologist of Moscow (Moscow, Russia)

Alla V. PLESKOVA – MD, PhD, Senior Researcher, Department of Pediatric Ophthalmology, Moscow Helmholtz Research Institute of Eye Diseases (Moscow, Russia)

Olga V. PROSKURINA – MD, PhD, Leading Researcher, Laboratory of Ergonomics in Ophthalmology and Optometry, Moscow Helmholtz Research Institute of Eye Diseases (Moscow, Russia)

Alla A. RJABCEVA – MD, PhD, Prof., Head of the Department of Ophthalmology, M.F. Vladimirskiy Moscow Regional Research and Clinical Institute (MONIKI) (Moscow, Russia)

Svetlana V. SAAKJAN – MD, PhD, Prof., Head of the Department of Ocular Oncology and Radiology, Moscow Helmholtz Research Institute of Eye Diseases (Moscow, Russia)

Elvira I. SAJDASHEVA – MD, PhD, Head of the Department of Pediatric Ophthalmology, North-Western State Medical University named after I.I. Mechnikov, Chief Visiting Pediatric Ophthalmologist of Saint Petersburg, (Saint Petersburg, Russia)

Olga V. HLEBNIKOVA – MD, PhD, Leading Researcher, Laboratory of Genetic Epidemiology, Research Center for Medical Genetics of the Russian Academy of Medical Sciences (Moscow, Russia)

Editorial Council:

Sergey E. AVETISOV – MD, PhD, Prof., Head of the State Research Institute of Eye Diseases of the Russian Academy of Medical Sciences, Head of the Department of Ophthalmology, I.M. Sechenov First Moscow State Medical University, Corresponding Member of the Russian Academy of Sciences (Moscow, Russia)

Yuri S. ASTAHOV – MD, PhD, Prof., Head of the Saint-Petersburg Center for Ophthalmology, Pavlov First Saint Petersburg State Medical University (Saint Petersburg, Russia)

Mukharram M. BIKBOV – MD, PhD, Prof., Head of the State Budgetary Institution Ufa Eye Research Institute of the Academy of Sciences of the Republic of Bashkortostan (Ufa, Russia)

Vladimir V. BRZHESKIJ – MD, PhD, Prof., Head of the Department of Ophthalmology, Vice-Rector for Education, State Budget Institution of Higher Professional Education Saint Petersburg State Pediatric Medical University of the Ministry of Health of the Russian Federation (Saint Petersburg, Russia)

Venera U. GALIMOVA – MD, PhD, Prof., First Deputy Director, Russian Eye and Plastic Surgery Center, Curriculum Director, Department of Eye and Plastic Surgery, Bashkir State Medical University (Ufa, Russia)

Sergey Yu. GOLUBEV – MD, PhD, Associate Prof., Department of Ophthalmology, National Pirogov Medical and Surgical Centre, Head of the “Organ Zreniya” Web Portal (www.organum-visus.com) (Moscow, Russia)

Evgeny A. EGOROV – MD, PhD, Prof., Academician of the Russian Academy of Natural Sciences, Academician of the Russian Academy of Medical and Technical Sciences, Academician of RAEN, Head of the Department of Ophthalmology, Medical Faculty, Pirogov Russian National Research Medical University, Chief Ophthalmologist, Medical Center of the Presidential Administration of the Russian Federation (Moscow, Russia)

Lyudmila N. ZUBAREVA – MD, PhD, Board Certified, Highest Category, Department of Ophthalmology, Federal State Institution Clinical Hospital of the Presidential Administration of the Russian Federation (Moscow, Russia)

Natalia A. KONOVALOVA – MD, PhD, Honored Doctor of the Russian Federation, Chief Physician of the Tyumen Regional Ophthalmology Specialized Early Treatment and Prevention Center, Head of the Department of Ophthalmology, Advanced Training Faculty, Tyumen State Medical University (Tyumen, Russia)

Sergey A. KOROTKIH – MD, PhD, Prof., Head of the Department of Ophthalmology, Ural State Medical University (Yekaterinburg, Russia)

Vladimir V. NEROEV – MD, PhD, Prof., Head of the Moscow Helmholtz Research Institute of Eye Diseases, Head of the Department of Ophthalmology, Faculty of Postgraduate Education, Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, Head of the Department of Retinal Disorders, Chief Visiting Ophthalmologist of the Ministry of Health of the Russian Federation, Honored Science Worker of Russia, Honored Doctor of the Russian Federation (Moscow, Russia)

Aleksandr V. POLTAVCEV – MD, Board Certified, Highest Category, Head of the Department of Ophthalmology, Bryansk Region Children’s Hospital, Chief Visiting Specialist of the Bryansk Region (Bryansk, Russia)

Natalia K. SEROVA – MD, PhD, Prof., Head of the Department of Ophthalmology, Burdenko Neurosurgery Institute (Moscow, Russia)

Olga S. SLEPOVA – MD, PhD, Prof., Head of the Laboratory of Immunology and Virology, Moscow Helmholtz Research Institute of Eye Diseases (Moscow, Russia)

Vladimir V. STRAHOV – MD, PhD, Prof., Head of the Department of Ophthalmology, Yaroslavl State Medical University (Yaroslavl, Russia)

Tatiana V. SUDOVSKAJA – MD, PhD, Head of the Pediatric Outpatient Department, Moscow Helmholtz Research Institute of Eye Diseases (Moscow, Russia)

Aleksandra V. HVATOVA – MD, PhD, Prof., Leading Specialist, Moscow Helmholtz Research Institute of Eye Diseases (Moscow, Russia)

Natalia B. CHESNOKOVA – PhD, Prof., Head of the Department of Pathophysiology and Biochemistry, Moscow Helmholtz Research Institute of Eye Diseases (Moscow, Russia)

Foreign Editorial Council Members:

Claire GILBERT – MD, Prof., International Center for Eye Health, Co-Director, International Center for Eye Health, Faculty of Infectious and Tropical Diseases, Department of Clinical Research (London, UK)

Michael T. TRESE – MD, Chief of Pediatric and Adult Vitreoretinal Surgery, William Beaumont Hospital-Royal Oak (Beaumont, USA)

Graham E. QUINN – MD, Prof., The Children’s Hospital of Philadelphia, Professor of Ophthalmology (Philadelphia, USA)

Nadezhda F. BOBROVA – MD, PhD, Prof., Honored Worker of Science and Technology of Ukraine, Head of the Department of Pediatric Ocular Diseases, Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine (Odessa, Ukraine)

Valentina F. IVANOVA – MD, PhD, Associate Prof., Department of Ophthalmology, Belarusian State Medical University, National Center for Pediatric Ophthalmology (Minsk, Belarus)

 

Indexation

 

Publication Ethics

The Ethic policy of "Russian Pediatric Ophthalmology" journal is based on recomendations from international commettees:

Reporting standarts

The Russian Pediatric Ophthalmology journal editorial team ask authors of reports of original research to present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable.

Review and professional publication articles should also be accurate and objective, and editorial opinion works should be clearly identified as such.

Data Access and Retention

Authors may be asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data (consistent with the ALPSP-STM Statement on Data and Databases), if practicable, and should in any event be prepared to retain such data for a reasonable time after publication.

Authorship clarified

The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before the work is submitted.

The Publisher does not prescribe the kinds of contributions that warrant authorship. It is recommended that authors adhere to the guidelines for authorship that are applicable in their specific research field. In absence of specific guidelines it is recommended to adhere to the following guidelines (based on ICMJE guidelines):

All authors whose names appear on the submission:

  1. made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software used in the work AND
  2. drafted the work or revised it critically for important intellectual content AND
  3. approved the version to be published AND
  4. agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Anyone who contributed to the research or manuscript preparation, but is not an author, should be acknowledged with their permission.

Submissions by anyone other than one of the authors will not be considered.

Research Ethics and Patient Consent (Statement of Human and Animal Rights)

Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study.

Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.

For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.

Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative. Please do not submit the patient’s actual written informed consent with your article, as this in itself breaches the patient’s confidentiality. The Journal requests that you confirm to us, in writing, that you have obtained written informed consent but the written consent itself should be held by the authors/investigators themselves, for example in a patient’s hospital record. The confirmatory letter may be uploaded with your submission as a separate file.

Please also refer to the ICMJE Recommendations for the Protection of Research Participants.

Hazards for Human or Animal Subjects

If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript. If the work involves the use of animal or human subjects, the authors should ensure that the manuscript contains a statement that all procedures were performed in compliance with relevant laws and institutional guidelines and that the appropriate institutional committee(s) have approved them. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.

When reporting experiments on animals, authors have to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.

Research involving human embryos, gametes, and stem cells

Manuscripts that report experiments involving the use of human embryos and gametes, human embryonic stem cells and related materials, and clinical applications of stem cells must include confirmation that all experiments were performed in accordance with relevant guidelines and regulations (See also Research involving human participants and/or animals)

The manuscript should include an ethics statement identifying the institutional and/or national research ethics committee (including the name of the ethics committee) approving the experiments and describing any relevant details. Authors should confirm that informed consent (See also Informed consent) was obtained from all recipients and/or donors of cells or tissues, where necessary, and describe the conditions of donation of materials for research, such as human embryos or gametes. Copies of approval and redacted consent documents may be requested by the Journal.

We encourage authors to follow the principles laid out in the 2016 ISSCR Guidelines for Stem Cell Research and Clinical Translation.

In deciding whether to publish papers describing modifications of the human germline, the Journal is guided by safety considerations, compliance with applicable regulations, as well as the status of the societal debate on the implications of such modifications for future generations. In case of concerns regarding a particular type of study the Journal may seek the advice from the Springer Nature Research Integrity Group.

The decision to publish a paper is the responsibility of the Editor-in-Chief of the Journal.

Use of inclusive language

Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Articles should make no assumptions about the beliefs or commitments of any reader, should contain nothing which might imply that one individual is superior to another on the grounds of race, sex, culture or any other characteristic, and should use inclusive language throughout. Authors should ensure that writing is free from bias, for instance by using 'he or she', 'his/her' instead of 'he' or 'his', and by making use of job titles that are free of stereotyping (e.g. 'chairperson' instead of 'chairman' and 'flight attendant' instead of 'stewardess').

Conflicts of Interest

The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to: patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.

Conflicts include the following:

  • Financial — funding and other payments, goods and services received or expected by the authors relating to the subject of the work or from an organization with an interest in the outcome of the work;
  • Affiliations — being employed by, on the advisory board for, or a member of an organization with an interest in the outcome of the work;
  • Intellectual property — patents or trademarks owned by someone or their organization;
  • Personal — friends, family, relationships, and other close personal connections;
  • Ideology — beliefs or activism, for example, political or religious, relevant to the work;
  • Academic — competitors or someone whose work is critiqued.

For more information on conflicts of interest, see the guidance from the ICMJE and WAME.

Funding and Acknowledgement of Sources

Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: https://www.crossref.org/services/funder-registry/  

Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work. Information obtained privately, as in conversation, correspondence, or discussion with third parties, must not be used or reported without explicit, written permission from the source. Information obtained in the course of confidential services, such as refereeing manuscripts or grant applications, must not be used without the explicit written permission of the author of the work involved in these services.

Plagiarism

Plagiarism takes many forms, from passing off another paper as the author(s) own paper, to copying or paraphrasing substantial parts of another(s) paper (without attribution), to claiming results from research conducted by others. Plagiarism in all its forms constitutes unethical publishing behavior and is unacceptable. Only original works are acceptable for publication in "Russian Pediatric Ophthalmology" journal. The journal does not allow any forms of plagiarism. Authors must not use the words, figures, or ideas of others without attribution. All sources must be cited at Russian Pediatric Ophthalmology journal take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. All the submitted articles are evaluated with plagiarism-checking software (Antiplagiat). Where an article, for example, is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgment, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to:

  • publishing an erratum or corrigendum (correction);
  • retracting the article;
  • taking up the matter with the head of department or dean of the author’s institution and/or relevant academic bodies or societies;
  • or taking appropriate legal action.

Also you can see ORI Avoiding Plagiarism, Self-plagiarism, and Other Questionable Writing Practices: A Guide to Ethical Writing

Duplicate Submission and Redundant Publication

Russian Pediatric Ophthalmology journal consider only original content, i.e. articles that have not been previously published, including in a language other than English. Articles based on content previously made public only on a preprint server, institutional repository, or in a thesis will be considered.

Manuscripts submitted to Russian Pediatric Ophthalmology journal must not be submitted elsewhere while under consideration and must be withdrawn before being submitted elsewhere. Authors whose articles are found to have been simultaneously submitted elsewhere may incur sanctions.

If authors have used their own previously published work, or work that is currently under review, as the basis for a submitted manuscript, they must cite the previous articles and indicate how their submitted manuscript differs from their previous work. Reuse of the authors’ own words outside the Methods should be attributed or quoted in the text. Reuse of the authors’ own figures or substantial amounts of wording may require permission from the copyright holder and the authors are responsible for obtaining this.

Russian Pediatric Ophthalmology journal will consider extended versions of articles published at conferences provided this is declared in the cover letter, the previous version is clearly cited and discussed, there is significant new content, and any necessary permissions are obtained.

Redundant publication, the inappropriate division of study outcomes into more than one article (also known as salami slicing), may result in rejection or a request to merge submitted manuscripts, and the correction of published articles. Duplicate publication of the same, or a very similar, article may result in the retraction of the later article and the authors may incur sanctions.

Citation Manipulation

Authors whose submitted manuscripts are found to include citations whose primary purpose is to increase the number of citations to a given author’s work, or to articles published in a particular journal, may incur sanctions.

Editors and reviewers must not ask authors to include references merely to increase citations to their own or an associate’s work, to the journal, or to another journal they are associated with.

Fundamental errors in published works, Corrections and Retractions

When an author discovers a significant error or inaccuracy in his/her own published work, it is the authors obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper.

If the editor or the publisher learn from a third party that a published work contains a significant error, it is the obligation of the author to promptly retract or correct the paper or provide evidence to the editor of the correctness of the original paper.

When errors are identified in published articles, the publisher will consider what action is required and may consult the editors and the authors’ institution(s). 

Errors by the authors may be corrected by a corrigendum, and errors by the publisher — by an erratum (see more).

If there are errors that significantly affect the conclusions or there is evidence of misconduct, this may require retraction or an expression of concern following the COPE Retraction Guidelines. All authors will be asked to agree to the content of the appropriate notice.

Sanctions

If Russian Pediatric Ophthalmology journal becomes aware of breaches of our publication ethics policies, the following sanctions may be applied:

  • Rejection of the manuscript and any other manuscripts submitted by the author(s).
  • Not allowing submission for 1–3 years.
  • Prohibition from acting as an editor or reviewer.

Russian Pediatric Ophthalmology journal may apply additional sanctions for severe ethical violations.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies